
Please try another search
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. The company holds the rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever in adults and children. It distributes its products primarily through drug wholesalers to anesthesiologists and surgeons, as well as nurse anesthetists, emergency medicine physicians, intensivists, internists, hospitalists, obstetricians, and other physicians. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California. As of March 18, 2014, Cadence Pharmaceuticals Inc. operates as a subsidiary of Mallinckrodt plc.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review